Epidemiologic reviews: Introduction and overview

Epidemiologic Reviews

Volumn 24, Issue 1, 2002, Pages 1-3

  Lavori, Philip W ^a,b,c   Kelsey, Jennifer ^a  

^a STANFORD UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; EDITORIAL; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH ECONOMICS; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0036305269     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/epirev/24.1.1     Document Type: Editorial

References (39)

1. Design of randomized trials
2. Analysis of randomized controlled trials
3. Management and conduct of randomized controlled trials
4. Regulatory issues for clinical trials in humans
5. Ethics in the design and conduct of clinical trials
6. Sample size calculations for randomized controlled trials
7. Comment: Neyman (1923) and causal inference in experiments and observational studies
8. On the application of probability theory to agricultural experiments. Essay on principles
9. Estimating causal effects of treatment in randomized and nonrandomized studies
10. Bayesian inference for causal effects: The role of randomization
11. Statistics and causal inference
12. Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism
13. Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model
14. G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients
15. The control of confounding by intermediate variables
16. Causal analysis in the health sciences
17. Comment: Neyman (1923) and causal inference in experiments and observational studies
18. Causal inference in a placebo-controlled clinical trial with binary outcome and ordered compliance
19. Beyond intention to treat
20. Special issues related to randomized trials of primary prevention
21. Community-based health intervention trials: An overview of methodological issues
22. Randomization by group: A formal analysis
23. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster
24. Economic endpoints in clinical trials
25. Bayesian approaches to randomized trials
26. Clinical and prophylactic trials with assured new treatment for those at greater risk. I. A design proposal
27. Clinical and prophylactic trials with assured new treatment for those at greater risk. II. Examples
28. Play the winner rule and the controlled clinical trial
29. The randomized play-the-winner rule in medical trials
30. A design for testing clinical strategies: Biased-coin adaptive within-subject randomization
31. Flexible treatment strategies in chronic disease: Clinical and research implications
32. Marginal mean models for dynamic regimes
33. Forcing a sequential experiment to be balanced
34. Minimization: A new method of assigning patients to treatment and control groups
35. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
36. Randomization, balance, and the validity and efficiency of design-adaptive allocation methods
37. The sample size for a clinical trial: A Bayesian-decision theoretic approach